top of page
gradientForSurfBreak.png

Item List

Jun 17, 2025
Morningstar
Materna Medical Announces Ellora™ and Additional Close on $20M Series B2

Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of a recent close within an ongoing $20 million Series B2 financing round. The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors Wavemaker Three-Sixty Health, Kimera Limited, Women's Venture Capital Fund, and Golden Seeds.

Recent Posts

Portfolio Company

Carlsmed.png

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Pr ...

Carlsmed

Feb 10, 2026

Portfolio Company

Carlsmed.png

xCures and the Colorectal Cancer Alliance Partner to Support Patient Access and ...

The National Law Review

Feb 5, 2026

Portfolio Company

Carlsmed.png

Vanguards of Health Care: Carlsmed Personalizes Spine with AI ...

Bloomberg

Feb 5, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page